Big three PBMs will testify before Congress next week, following FTC report

Pharmacy benefit manager executives from Cigna, CVS Health and UnitedHealth Group are scheduled to testify before Congress on July 23, giving lawmakers a chance to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Vandria raises another $10M; Nykode ends Phase 2 trial in cervical cancer

Plus, news about Retension Pharmaceuticals: Vandria tops up Series A with another $10M: The Swiss biotech increased its round total to … Sign up to

August 22, 2024

Precision, Imugene conclude transaction for cancer treatment

The licence provides Imugene with an option to develop up to three other cancer research programmes. Credit: Doodlart from Pixabay. Precision Biosciences and Imugene have

August 16, 2023

Navigating 2024 Healthcare Challenges: Policy, AI, and the Road Ahead

Bill Charnetski, EVP of Health System solutions and Government Affairs at PointClickCare Now that we’re halfway through 2024, we’ve gained significant insights into the most

October 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.